Lorcan Redmond, Professional Tri-Athlete Uses Signia Active to Optimize Performance in All Situations

Lorcan Redmond appreciates the outstanding sound quality provided by Signia Active, which is complemented by its all-new state-of-the-art Bluetooth streaming option, allowing him to listen to his music, watch videos from his phone and take phone calls with the audio feeding direct into the device all while he is on the go. View his video here.

Wearing Signia Active hearing aids means Lorcan Redmond can now stand on the starting line with 70 other triathletes and hear the subtle sounds many of us take for granted. He can ride a bike on an open road, listen to music and hear if there are cars behind him. He can clearly hear the instructions of his coach and not miss conversations with his teammates, family, and friends.

“With a product like Signia Active, there is no excuse to not act on hearing loss and get what you need to help you live a fuller life,” Lorcan Redmond concludes. “The technology is so great that I put these in and think I’m wearing headphones, but I can just hear a lot better.”

Signia Active has been a game-changer for Lorcan Redmond, both personally and professionally, making him more confident, determined, and open about his hearing loss. He is currently training for the World Championships, scheduled for the end of this year, with the ultimate goal of heading to Birmingham next year for the 2022 Commonwealth Games.

SourceSignia
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version